Genotype-guided clopidogrel alone after stent placement
Treatments studied
Part of Heart & circulation clinical trials.
This trial looks at whether using clopidogrel by itself (without aspirin) works for people after a new drug-eluting stent, based on a blood test of how your body processes the drug. It may help reduce “extra blood-thinning” if you have a certain genetic type that responds well to clopidogrel.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and had NSTEMI or unstable angina (an “ACS” heart problem)
- You had a successful PCI procedure and received a new drug-eluting stent
- Your genetic test shows you are an “extensive” or “ultra-rapid” metabolizer for CYP2C19
- You do not have a known allergy or medical reason you cannot take aspirin or clopidogrel
- You are not taking oral blood thinners (like warfarin or DOACs) at the same time
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether choosing a blood thinner based on your DNA can prevent more heart problems. If you've had a complex heart procedure, you may be able to get a medication that works best for your body.
This trial studies whether changing the timing and type of blood-thinner tablets after a heart stent is as safe and effective as continuing the same plan. It may help some people by simplifying treatment while preventing dangerous clotting after a coronary procedure.
This trial tests whether using a rapid genetic test to choose antiplatelet medication can improve outcomes for people who have had a stroke or mini-stroke. The test checks a gene that affects how your body processes a common antiplatelet drug, so your doctors can pick the safest and most effective medicine for you.
This study compares ticagrelor taken at a lower dose versus regular aspirin to help prevent future heart attacks in people who recently had a stent placed after acute coronary syndrome. You may qualify if you’re considered “high risk” for new blockages or clots and can take dual anti-platelet therapy for 12 months.
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
This trial tests whether a genetic test can help doctors choose the best blood-thinning medicine for people with heart disease who are having a stent placed. The goal is to reduce the risk of blood clots or bleeding after the procedure.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.